Publications
- Chelators as Antineuroblastomas Agents2023 | First Faculty of Medicine
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells2022 | First Faculty of Medicine
- Dimethinium Heteroaromatic Salts as Building Blocks for Dual-Fluorescence Intracellular Probes2017 | First Faculty of Medicine
- Use of new types of pentamethinine salts with expanded quinoxaline unit in antitumor therapyPublication without faculty affiliation
- Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication2023 | First Faculty of Medicine
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- TET protein inhibitors: Potential and limitations2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration2022 | First Faculty of Medicine, Faculty of Science
Loading network view...
